# Effects of Treatment With N- Acetylcysteine on Visual Outcomes in Patients With Retinitis Pigmentosa

> **NCT04864496** · PHASE2 · UNKNOWN · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 30 (estimated)

## Conditions studied

- Retinitis Pigmentosa

## Interventions

- **DRUG:** Prescribe N-acetylcysteine tablets
- **DRUG:** Prescribe placebo tablets

## Key facts

- **NCT ID:** NCT04864496
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-17
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-12-20
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04864496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04864496, "Effects of Treatment With N- Acetylcysteine on Visual Outcomes in Patients With Retinitis Pigmentosa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04864496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*